Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Brands

Road

Astana’s Fedosseyev tests positive for anabolic steroids

A third Astana Continental team rider has been snared by anti-doping tests. Five riders associated with Astana have now tested positive

Don't miss a moment from Paris-Roubaix and Unbound Gravel, to the Giro d’Italia, Tour de France, Vuelta a España, and everything in between when you join Outside+.

The Union Cycliste Internationale (UCI) announced Wednesday that Artur Fedosseyev, a rider for Astana’s Continental team, tested positive for anabolic androgenic steroids in an anti-doping sample collected at the Tour de l’Ain on August 16, 2014.

This is the fifth positive doping test linked to the Astana team this season, after the Iglinskiy brothers, Ilya Davidenok, and Victor Okishev all tested positive for banned substances in the second half of the 2014.

The UCI has provisionally suspended Fedosseyev, 20, and it remains to be seen if the Kazakhstani will request a B sample test.

After the third of the five positive tests, the UCI asked its license commission to undertake a full review of the management and anti-doping policies of the Astana team.

A decision has yet to be made whether or not to grant Astana a WorldTour license for 2015.

Astana was excluded from the 2008 Tour de France after a series of doping scandals at that time, denying then-Tour champion Alberto Contador the opportunity to defend his title.

It was also the time when current team manager Alexandre Vinokourov was an Astana rider and was himself serving a two-year ban for a blood transfusion.

Astana was interviewed by the UCI earlier this month with relation to its internal drug-testing policies and subsequently announced a collaboration with Kazakhstan’s anti-doping agency to monitor their riders’ biological passports.